Navigation Links
Shandon Excelsior ES™ Tissue Processor

ProductsShandon Excelsior ES™ Tissue Processor
Company ThermoFisher Scientific
Item Shandon Excelsior ES™ Tissue Processor
Features 
  • Daily Operations Mode - an easy-to-use operating mode for routine operation of the Shandon Excelsior ES.
  • Daily operators may select and start a processing run or a flush cycle with one key press.
  • When needed, the Menu Mode delivers all the functionality that the Shandon Excelsior ES has to offer.
  • The Quality Control screen will allow the daily user to acknowledge rotation requests; approved users may also change rotation parameters when accessing the Quality Control screen from the Menu mode.
  • Access to the Menu Mode functions may be user-protected to prevent inexperienced users from changing programs or setup parameters.
  • Wax bath levels may be easily verified by simply opening the cabinet doors for viewing no need to remove the waste wax tray.
Description Shandon Excelsior ES Tissue Processor continues the Thermo Electron Corporation tradition of offering one of the most advanced, traditional reagent instruments available today.
Info ThermoFisher Scientific
Customer Service: (800) 637-3717
Web site: http://www.thermofisher.com/global/en/home.asp

Related medicine products :

1. Shandon Benchtop Fume Expeller
2. Shandon Hyperclean 20 Fume Handling Station
3. Shandon Hyperclean 22 Fume Handling Station
4. Shandon Hyperclean 2 Fume Handling Station
5. Shandon Hyperclean 36 Fume Handling Station
6. Shandon Hyperclean 60 Fume Handling Station
7. Shandon Gross-Star Grossing Workbench
8. Shandon Grosslab Junior Grossing Workstation
9. Shandon Hyperclean 1 Fume Handling Station
10. Shandon Gross-Star Grossing Workstation
11. Shandon Grosslab Senior Grossing Workstation
Breaking Medicine News(10 mins):Health News:Unanimous Vote Creates Largest RN Union in U.S. History 2Health News:Senator Ben Nelson Puts U.S. Bishops' Interests Ahead of Americans' Healthcare Needs 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:Pitt study suggests craving hinders comprehension without your realizing it 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5
Other Medicine News:Health News:New Employee of the Nations Largest Healthcare Consulting Firm 2Health News:Rochester study raises new questions about controversial plastics chemical 2Health News:Rochester study raises new questions about controversial plastics chemical 3Health News:Courage Center Experts Disagree With Gov. Pawlenty's Proposed Budget Cuts 2Health News:Courage Center Experts Disagree With Gov. Pawlenty's Proposed Budget Cuts 3Health News:Salmonella Outbreak Plant Shipped Dubious Product Before: U.S. Health Officials 2Health News:Salmonella Outbreak Plant Shipped Dubious Product Before: U.S. Health Officials 3Health News:Ringling Bros. and Barnum & Bailey(R) Proudly Announces Its First Elephant Calf Born From Artificial Insemination 2Health News:Ringling Bros. and Barnum & Bailey(R) Proudly Announces Its First Elephant Calf Born From Artificial Insemination 3Health News:Ringling Bros. and Barnum & Bailey(R) Proudly Announces Its First Elephant Calf Born From Artificial Insemination 4Health News:Ringling Bros. and Barnum & Bailey(R) Proudly Announces Its First Elephant Calf Born From Artificial Insemination 5Health News:C8 Science Panel Completes Uric Acid Study 2
Breaking Medicine Technology:Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 2Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 3Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 4Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 2Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 3Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 4Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 5Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 6Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Sigma Aldrich 28R 29 and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement 14347 1Sigma Aldrich 28R 29 and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement 14347 2Sigma Aldrich 28R 29 and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement 14347 3Sigma Aldrich 28R 29 and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement 14347 4Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre Deploys Isilon IQ in Next Generation of Drug Development 5206 1Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre Deploys Isilon IQ in Next Generation of Drug Development 5206 2Frost 26amp 3B Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year 5205 1Frost 26amp 3B Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year 5205 2Frost 26amp 3B Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year 5205 3Frost 26amp 3B Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year 5205 4